BCOR and myelodysplastic syndrome: However, BCOR mutation rates of male patients were lower in other male predominat malignancies (myelodysplastic syndrome (MDS), 3.8% of men vs 6.5% of women [31]; acute myeloid leukemia (AML), 5.5% of men vs 6.9% of women [32]; EBV-positive gastric cancer (EBV-GC), 14.2% of men vs 20% of women [33]).